SuperworthBio Green Med Solution BGMS
- Market cap
- $6.4M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- n/m
- one or more of the four quarters through 2026-06-30 missing
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Free cash flow yield
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $16K | $31K | $29K | $4K−99% | $10K−38% | $0 | n/a | n/a | $81K+710% | n/a | $778K | $336K | |
| Cost of revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| R&D | $5.2M+19% | $3.5M−48% | $2.8M−51% | $2M−57% | $950K−82% | $880K−75% | $822K−71% | $68K−97% | $5K−100% | n/a | n/a | n/a |
| SG&A | $1.6M−21% | $1.9M−13% | $1.6M−4% | $1.6M+3% | $1.2M−24% | $948K−49% | $4.2M+166% | $1.2M−23% | $1M−19% | n/a | $389K−91% | $497K−60% |
| −$6.8M+6% | −$5.4M−39% | −$4.4M−41% | −$3.6M−39% | −$2.2M−68% | −$1.8M−66% | −$4.2M−3% | −$1.2M−66% | −$992K−54% | n/a | −$246K−94% | −$418K−67% | |
| Interest expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | −$6.7M+10% | −$5.7M−37% | −$4.3M−40% | −$3.7M−39% | −$2.2M−68% | −$1.9M−67% | −$4.2M−2% | −$1.2M−66% | −$988K−54% | n/a | −$167K−96% | −$396K−68% |
| −$668K−34% | −$422K−73% | −$1.4M+3% | −$412K−30% | −$210K−69% | $1.2M | n/a | $2K | $0 | n/a | $30K | $9K+350% | |
| Net income | −$6M+18% | −$5.3M−29% | −$2.9M−49% | −$3.3M−40% | −$2M−68% | −$3.1M−42% | −$81K−97% | −$1.3M−60% | −$988K−50% | −$611K−80% | −$197K+143% | −$405K−69% |
| n/a | n/a | −$544.80−68% | −$172.18−89% | −$43.80 | n/a | −$11.52−98% | −$0.93−100% | −$1.31−97% | n/a | −$0.04−100% | −$0.08−91% | |
| n/a | n/a | 5.4K+55% | 18.9K+443% | 44.7K | n/a | 365.2K+6654% | 1.4M+7093% | 1.9M+4180% | n/a | 5.5M+1395% | 5.6M+312% |
EPS, diluted: 12 periods, Q4 FY11 to Q4 FY22: quarter's net income to common over its shares, to the cent.
Diluted shares: 13 periods, Q1 FY11 to Q2 FY24: not printed by the filing, worked out from its own lines. 9 periods, Q4 FY14 to Q4 FY22: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Industrials nearest Bio Green Med Solution's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BGMSBio Green Med Solution | $6.4M | n/m | n/a | n/m | n/m | n/m | |
| AERTAeries Technology | $32.1M | 14.2× | 30.3× | 0.4× | +11% | 4.7% | |
| MAMOMassimo | $39.5M | 9.5× | 14.4× | 0.6× | −17% | 6.0% | |
| ACFNAcorn Energy | $43.3M | 28.3× | 54.0× | 4.5× | −28% | 16.1% | |
| Peer median | $39.5M | 14.2× | 30.3× | 0.6× | −17% | 6.0% |
More on Bio Green Med Solution
Each number over time
Its groups
About
- Industry
- Industrial - Distribution
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .